ATE420360T1 - Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm- erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae - Google Patents

Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm- erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae

Info

Publication number
ATE420360T1
ATE420360T1 AT02786532T AT02786532T ATE420360T1 AT E420360 T1 ATE420360 T1 AT E420360T1 AT 02786532 T AT02786532 T AT 02786532T AT 02786532 T AT02786532 T AT 02786532T AT E420360 T1 ATE420360 T1 AT E420360T1
Authority
AT
Austria
Prior art keywords
disease
ulcerative colitis
crohn
saccharomyces cerevisiae
detecting
Prior art date
Application number
AT02786532T
Other languages
English (en)
Inventor
James Boone
David Lyerly
Tracy Wilkins
Original Assignee
Techlab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Techlab Inc filed Critical Techlab Inc
Application granted granted Critical
Publication of ATE420360T1 publication Critical patent/ATE420360T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02786532T 2001-10-26 2002-10-26 Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm- erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae ATE420360T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33581201P 2001-10-26 2001-10-26
US10/280,564 US6872540B2 (en) 2001-10-26 2002-10-25 Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae

Publications (1)

Publication Number Publication Date
ATE420360T1 true ATE420360T1 (de) 2009-01-15

Family

ID=26960364

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02786532T ATE420360T1 (de) 2001-10-26 2002-10-26 Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm- erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae

Country Status (7)

Country Link
US (2) US6872540B2 (de)
EP (1) EP1444519B1 (de)
AT (1) ATE420360T1 (de)
AU (1) AU2002349942B2 (de)
CA (1) CA2464466A1 (de)
DE (1) DE60230792D1 (de)
WO (1) WO2003036262A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4395070B2 (ja) 2002-06-25 2010-01-06 インデックス・ダイアグノスティックス・アクチエボラーグ 潰瘍性大腸炎を診断するための方法およびキット
WO2004022713A2 (en) * 2002-09-05 2004-03-18 Techlab, Inc. Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca)
AU2003284187B2 (en) * 2002-10-25 2009-10-01 Techlab, Inc. Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panel
US7592150B2 (en) 2003-12-03 2009-09-22 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
EP1692519B1 (de) 2003-12-03 2010-06-02 Glycominds Ltd. Diagnostikverfahren mittels messungen der antiglykan-antikörper-spiegeln
US20070121939A1 (en) * 2004-01-13 2007-05-31 Interdigital Technology Corporation Watermarks for wireless communications
US7904723B2 (en) * 2005-01-12 2011-03-08 Interdigital Technology Corporation Method and apparatus for enhancing security of wireless communications
US7943328B1 (en) 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20100094560A1 (en) * 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
WO2009069007A2 (en) * 2007-11-30 2009-06-04 Glycominds, Ltd. Composition and method for prediction of complicated disease course and surgeries in crohn's disease
CA2747253A1 (en) 2007-12-20 2009-07-02 Index Diagnostics Ab Method and kit for use in the differentiation of ibd and ibs and further distinction between disease types of ibd
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
WO2021146562A1 (en) * 2020-01-15 2021-07-22 Board Of Regents Of The University Of Nebraska Anti-maa immunoglobulin isotypes in inflammatory bowel disease: diagnostic implications for ulcerative colitis
CN112708568B (zh) * 2021-01-29 2023-03-21 上海理工大学 一种具有缓解急性结肠炎功能的酿酒酵母
GB2639381A (en) * 2022-09-30 2025-09-24 Kimberly Clark Co Methods and absorbent articles for inhibiting fecal protease activity

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693043A (en) * 1985-03-22 1997-12-02 Massachusetts Institute Of Technology Catheter for laser angiosurgery
US4953247A (en) * 1988-05-09 1990-09-04 Hasty Charles E Air-operated body support device
US5359038A (en) * 1992-07-14 1994-10-25 Eloy Padron Method for isolating immunoglobulin compounds in the feces
US5462852A (en) * 1992-10-28 1995-10-31 The Government Of The United States Of America, As Represented By The Secretary, Dhhs HIV Nucleocapsid protein capture assay and method of use
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US5874233A (en) 1996-04-12 1999-02-23 Cedars-Sinai Medical Center Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis
US5932429A (en) * 1996-04-12 1999-08-03 Cedars-Sinai Medical Center Methods of diagnosing clinical subtypes of crohn's disease
US5855577A (en) * 1996-09-17 1999-01-05 Eclipse Surgical Technologies, Inc. Bow shaped catheter
US6042581A (en) * 1996-11-08 2000-03-28 Thomas J. Fogarty Transvascular TMR device and method
US5968741A (en) * 1997-04-11 1999-10-19 Cedars-Sinai Medical Center Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis
US6218129B1 (en) 1998-05-15 2001-04-17 Prometheus Laboratories, Inc. Inflammatory bowel disease first step assay system
DE60044522D1 (de) * 1999-04-08 2010-07-22 Synergetics Inc Gerichtete lasersonde
US6667160B2 (en) * 2000-03-15 2003-12-23 Kenneth D. Fine Method for diagnosing immunologic food sensitivity
US6984230B2 (en) * 2000-04-07 2006-01-10 Synergetics, Inc. Directional laser probe

Also Published As

Publication number Publication date
CA2464466A1 (en) 2003-05-01
EP1444519B1 (de) 2009-01-07
EP1444519A2 (de) 2004-08-11
WO2003036262A3 (en) 2003-07-03
US6872540B2 (en) 2005-03-29
AU2002349942B2 (en) 2007-11-01
US20050136495A1 (en) 2005-06-23
US20030143649A1 (en) 2003-07-31
WO2003036262A2 (en) 2003-05-01
EP1444519A4 (de) 2006-01-11
DE60230792D1 (de) 2009-02-26

Similar Documents

Publication Publication Date Title
ATE420360T1 (de) Verfahren zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm- erkrankungen durch nachweis des vorhandenseins von fäkalen antikörpern gegen saccharomyces cerevisiae
DE602004021367D1 (de) Verfahren zur beurteilung des phänotyps eines patienten mit morbus crohn über eine serologische i2-, ompc- und asca-reaktion
ATE395596T1 (de) Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon
DE69936523D1 (de) Assaysystem zur erstbehandlung von darmerkrankungen
EE05465B1 (et) Meetod allergeeniga seostuva immunoglobuliini detekteerimiseks proovis, patsiendi allergiate in vitro diagnoosimeetod, mikromaatrikskiip ja komplekt
TW200512457A (en) Method of diagnosing SARS corona virus infection
DE60228557D1 (de) Candida-nachweis
DK1631312T3 (da) Sammensætning og fremstillingsmåde til behandling af inflammatorisk tarmsygdom
ITRM20030386A1 (it) Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici.
DE602005022924D1 (de) Verfahren zur diagnose von morbus crohn
NO960924D0 (no) Analysesett
EP1643894A4 (de) Verfahren, kits und antikörper zum nachweis von parathyroid
EP1537415A4 (de) VERFAHREN ZUR DIAGNOSE VON GEBûRMUTTERHALSKREBS
WO2007001737A3 (en) Methods and compositions for detecting herpes simplex virus type 2
BRPI0200986B8 (pt) método de determinação da presença de hcv em uma amostra
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
DE60228952D1 (de) Nachweis von Legionella durch ein PCR und FRET verwendendes Verfahren
BRPI0414784A (pt) método e dispositivo para detectar quantidades muito pequenas de partìculas
FR2900936B1 (fr) Procede et methodes de detection de la maladie d'alzheimer
ATE538128T1 (de) Verfahren zur unterscheidung von colitis ulcerosa von morbus crohn durch nachweis des vorliegens von fäkalen anti-neutrophilen cytoplasmatischen antikörpern (anca)
DE60038557D1 (en) Assay
DK2095126T3 (da) Fremgangsmåde til påvisning af humant parvovirusantigen
DE50208504D1 (de) Messvorrichtung zur konzentrationsbestimmung von gasen durch ir-absorption
GB0223655D0 (en) Method of diagnosis
HK1114534A (en) Methods and compositions for detecting herpes simplex virus type 2

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties